News - Preferred Networks, Inc.

2022.02.28

Kao and PFN Co-Develop Virtual Human Body Generative Model

Companies to evaluate statistical model that estimates over 1,600 attributes related to health, lifestyle and more ...Read More

News Release

#biohealthcare #life sciences

2021.09.21

Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease

Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease ...Read More

News Release

#biohealthcare

2021.09.06

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development ...Read More

News Release

#biohealthcare #drug discovery

2021.06.04

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021 ...Read More

Topics

#biohealthcare

2021.04.05

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis ...Read More

News Release

#biohealthcare #drug discovery

2020.10.12

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images ...Read More

News Release

#biohealthcare

2019.11.20

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology ...Read More

News Release

#biohealthcare

2018.11.15

Mitsui and Preferred Networks to Establish Joint Venture to Provide Biomedical/Healthcare Solutions, Including Cancer Diagnostic Service, Based on Deep Learning Technology

Mitsui and Preferred Networks to Establish Joint Venture to Provide Biomedical/Healthcare Solutions, Including Cancer Diagnostic Service, Based on Deep Learning Technology ...Read More

News Release

#Preferred Medicine #biohealthcare #biohealthecare

2018.10.29

Preferred Networks and PFDeNA launch joint research project to develop a deep learning-based system to detect 14 types of cancers with a small amount of blood

2021年を目標に社会実装し、がんの早期発見・健康寿命延伸を目指す ...Read More

News Release

#PFDeNA #biohealthcare

2018.07.26

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron ...Read More

News Release

#biohealthcare #funding

2022.02.28

Kao and PFN Co-Develop Virtual Human Body Generative Model

Companies to evaluate statistical model that estimates over 1,600 attributes related to health, lifestyle and more ...Read More

News Release

#biohealthcare #life sciences

2021.09.21

Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease

Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease ...Read More

News Release

#biohealthcare

2021.09.06

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development ...Read More

News Release

#biohealthcare #drug discovery

2021.06.04

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021 ...Read More

Topics

#biohealthcare

2021.04.05

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis ...Read More

News Release

#biohealthcare #drug discovery

2020.10.12

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images ...Read More

News Release

#biohealthcare

2019.11.20

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology ...Read More

News Release

#biohealthcare

2018.11.15

Mitsui and Preferred Networks to Establish Joint Venture to Provide Biomedical/Healthcare Solutions, Including Cancer Diagnostic Service, Based on Deep Learning Technology

Mitsui and Preferred Networks to Establish Joint Venture to Provide Biomedical/Healthcare Solutions, Including Cancer Diagnostic Service, Based on Deep Learning Technology ...Read More

News Release

#Preferred Medicine #biohealthcare #biohealthecare

2018.10.29

Preferred Networks and PFDeNA launch joint research project to develop a deep learning-based system to detect 14 types of cancers with a small amount of blood

2021年を目標に社会実装し、がんの早期発見・健康寿命延伸を目指す ...Read More

News Release

#PFDeNA #biohealthcare

2018.07.26

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron ...Read More

News Release

#biohealthcare #funding

biohealthcare

Kao and PFN Co-Develop Virtual Human Body Generative Model

Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology

Mitsui and Preferred Networks to Establish Joint Venture to Provide Biomedical/Healthcare Solutions, Including Cancer Diagnostic Service, Based on Deep Learning Technology

Preferred Networks and PFDeNA launch joint research project to develop a deep learning-based system to detect 14 types of cancers with a small amount of blood

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron

Kao and PFN Co-Develop Virtual Human Body Generative Model

Juntendo, Kao and PFN Discover Skin Surface Lipids-RNA Patterns Specific to Patients with Parkinson’s Disease

PFN Develops AI Drug Discovery Technology That Accelerates Initial Screening for Pharmaceutical Development

Preferred Medicine Announces Presentation on Machine Learning-based Early Cancer Detections with Blood miRNAs at American Society of Clinical Oncology 2021

Curreio and PFN Collaborate on Drug Discovery Using Deep Learning and Structural Analysis

Preferred Networks Uses Deep Learning to Help Kyoto Physicians Diagnose Lung Cancer from Chest X-Ray Images

Kao and Preferred Networks Launch a Collaborative Project for Practical Applications of Sebum RNA Monitoring Technology

Mitsui and Preferred Networks to Establish Joint Venture to Provide Biomedical/Healthcare Solutions, Including Cancer Diagnostic Service, Based on Deep Learning Technology

Preferred Networks and PFDeNA launch joint research project to develop a deep learning-based system to detect 14 types of cancers with a small amount of blood

Preferred Networks raises a total of about 900 million yen in capital from Chugai Pharmaceutical and Tokyo Electron

Join the PFN team

Join the PFN team

Contact us for inquiries on
our products, solutions and R&D

Contact us for inquiries on
our products, solutions and R&D